Researchers overcome major roadblock to unleash efficiencies of promising tech for electronic displays, solar panel ...

What’s driving this surge? Insmed revealed that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension (PAH) achieved..